Daniel Mark Bradbury

Executive Chairman at Equillium, Inc.

Daniel Mark Bradbury

Daniel Mark Bradbury

Executive Chairman at Equillium, Inc.

Overview
Career Highlights

Biolinq, Inc.
Equillium, Inc.
Sensulin LLC

RelSci Relationships

1958

Number of Boards

42

Birthday

1961

Age

60

Relationships
RelSci Relationships are individuals Daniel Mark Bradbury likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Biocon Ltd.

Relationship likelihood: Strong

Founder at Castle Biosciences, Inc.

Relationship likelihood: Strong

President & Professor, KGI at Keck Graduate Institute of Applied Life Sciences

Relationship likelihood: Strong

Co-Founder at Intercept Pharmaceuticals, Inc.

Relationship likelihood: Strong

Director at Cigna Corp.

Relationship likelihood: Strong

Executive Chairman at Appello Pharmaceuticals, Inc.

Relationship likelihood: Strong

Member & Supervisory Board at MorphoSys AG

Relationship likelihood: Strong

Vice Chairman at American Diabetes Association Research Foundation, Inc.

Relationship likelihood: Strong

Co-Founder at Batu Biologics, Inc.

Relationship likelihood: Strong

Professional at Theragence, Inc.

Relationship likelihood: Strong

Paths to Daniel Mark Bradbury
Potential Connections via
Relationship Science
You
Daniel Mark Bradbury
Executive Chairman at Equillium, Inc.
Education
Bachelor of Pharmacy
Class of 1983

The University of Nottingham shares many of the characteristics of the world's great universities. However, they are distinct not only in their key strengths but in how their many strengths combine: they are financially secure, campus based and comprehensive; they are research-led and recruit top students and staff from around the world; they are committed to internationalising all their core activities so their students can have a valuable and enjoyable experience that prepares them well for the rest of their intellectual, professional and personal lives.

Diploma in Management Studies
Diploma Management Studies

Harrow College offers academic and vocational courses with choices of A Level, BTEC, TechBac, NVQ, Traineeships, and Apprenticeships.

Memberships
Member
Current

Royal Pharmaceutical Society of Great Britain is a British private company located in London that provides expertise and support to its member pharmacists. Alex MacKinnon is the current CEO, occupying that position since 2010.

Career History
Executive Chairman
2017 - Current

Biolinq, Inc. develops skin-applied electronic sensors that analyze body fluids to provide health information. The company was founded by Jared Tangney and Josh Windmiller in 2012 and is headquartered in San Diego, CA.

Executive Chairman
2017 - Current

Equillium, Inc. is a biotechnology company, which engages in the development of products for severe immuno-inflammatory disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly on March 16, 2017 and is headquartered in La Jolla, CA.

Chairman
Current

Sensulin LLC engages in a biotechnology company. It develops once-a-day glucose responsive insulin that may mimic a healthy human pancreas. The company was founded by Mike Moradi, Ananth Annapragada, Daniel M. Bradbury, and Chris A. Rhodes and is headquartered in Oklahoma City, OK.

Boards & Committees
Director
2014 - Current

Renova Therapeutics, Inc. operates as a biopharmaceutical company. The firm is developing definitive, one-time gene therapies and peptide infusion treatments to restore the health of people suffering from chronic diseases. Its product, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in patients with CHF. The company was founded by Jack W. Reich, H. Kirk Hammond and Craig Andrews in 2009 and is headquartered in San Diego, CA.

Director
2013 - Current

Profil Institute for Clinical Research, Inc. operates as a full-service clinical research organization (CRO), that focuses on diabetes, obesity and NAFLD/NASH. It offers clinical development, regulatory affair, clinical research, scientific, data management and statistical, monitoring, quality and compliance, and recruitment services. The company was founded in 2004 and is headquartered in Chula Vista, CA.

Director
Current

BioMed Realty LP owns, acquires, develops, redevelops, leases, manages laboratory and office space. The company was founded on April 30, 2004 and is headquartered in San Diego, CA.

Director
Current
Director & Chairman
Prior

BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$25K - $50K
2010

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND focuses on the issues that matter most such as health, education, national security, international affairs, law and business, the environment, and more. With a research staff consisting of some of the world's preeminent minds, RAND has been expanding the boundaries of human knowledge for more than 60 years. As a nonpartisan organization, RAND is widely respected for operating independent of political and commercial pressures. See History and Mission. RAND's tradition of problem-solving continues to this day. Much of this research is carried out on behalf of public and private grantors and clients. Philanthropic dollars help support RAND's Investment in People and Ideas program, our vehicle for funding research inquiries into critical but often underappreciated policy areas and attracting the world's top talent to focus on these challenges. All RAND work—every publication, database, or major briefing—is held to rigorous and sometimes painstaking review processes. Such exacting standards are the foundation of RAND's impeccable reputation throughout the world. See Standards for High Quality Research and Analysis and RAND's Institutional Principles. RAND improves policy and decisionmaking through research and analysis. At times, grantors or clients may ask RAND to deliver research without suggesting a specific course of action. At other times, RAND may provide a range of solutions with an analysis of advantages and disadvantages. On certain occasions, RAND may formulate or even support clear-cut policy recommendations. What remains constant is RAND's commitment to public service by communicating its findings to a wide audience. This is accomplished in many ways. They include announcements to media, testimony by experts at RAND (often to the U.S. Congress), and publications, many of which are available free on this Web site. See Newsroom, Congressional Resources, and Reports and Bookstore. RAND in the 21st century continues to address difficult challenges throughout the world. In many ways, RAND's future reflects its past: anticipating emerging issues; establishing new angles of inquiry; and mapping the territory for responses by government, business, and society. Commitment to these high standards will continue to define RAND's work in the years to come.

$25K - $50K
2009

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND focuses on the issues that matter most such as health, education, national security, international affairs, law and business, the environment, and more. With a research staff consisting of some of the world's preeminent minds, RAND has been expanding the boundaries of human knowledge for more than 60 years. As a nonpartisan organization, RAND is widely respected for operating independent of political and commercial pressures. See History and Mission. RAND's tradition of problem-solving continues to this day. Much of this research is carried out on behalf of public and private grantors and clients. Philanthropic dollars help support RAND's Investment in People and Ideas program, our vehicle for funding research inquiries into critical but often underappreciated policy areas and attracting the world's top talent to focus on these challenges. All RAND work—every publication, database, or major briefing—is held to rigorous and sometimes painstaking review processes. Such exacting standards are the foundation of RAND's impeccable reputation throughout the world. See Standards for High Quality Research and Analysis and RAND's Institutional Principles. RAND improves policy and decisionmaking through research and analysis. At times, grantors or clients may ask RAND to deliver research without suggesting a specific course of action. At other times, RAND may provide a range of solutions with an analysis of advantages and disadvantages. On certain occasions, RAND may formulate or even support clear-cut policy recommendations. What remains constant is RAND's commitment to public service by communicating its findings to a wide audience. This is accomplished in many ways. They include announcements to media, testimony by experts at RAND (often to the U.S. Congress), and publications, many of which are available free on this Web site. See Newsroom, Congressional Resources, and Reports and Bookstore. RAND in the 21st century continues to address difficult challenges throughout the world. In many ways, RAND's future reflects its past: anticipating emerging issues; establishing new angles of inquiry; and mapping the territory for responses by government, business, and society. Commitment to these high standards will continue to define RAND's work in the years to come.

$30K - $100K
2008

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND focuses on the issues that matter most such as health, education, national security, international affairs, law and business, the environment, and more. With a research staff consisting of some of the world's preeminent minds, RAND has been expanding the boundaries of human knowledge for more than 60 years. As a nonpartisan organization, RAND is widely respected for operating independent of political and commercial pressures. See History and Mission. RAND's tradition of problem-solving continues to this day. Much of this research is carried out on behalf of public and private grantors and clients. Philanthropic dollars help support RAND's Investment in People and Ideas program, our vehicle for funding research inquiries into critical but often underappreciated policy areas and attracting the world's top talent to focus on these challenges. All RAND work—every publication, database, or major briefing—is held to rigorous and sometimes painstaking review processes. Such exacting standards are the foundation of RAND's impeccable reputation throughout the world. See Standards for High Quality Research and Analysis and RAND's Institutional Principles. RAND improves policy and decisionmaking through research and analysis. At times, grantors or clients may ask RAND to deliver research without suggesting a specific course of action. At other times, RAND may provide a range of solutions with an analysis of advantages and disadvantages. On certain occasions, RAND may formulate or even support clear-cut policy recommendations. What remains constant is RAND's commitment to public service by communicating its findings to a wide audience. This is accomplished in many ways. They include announcements to media, testimony by experts at RAND (often to the U.S. Congress), and publications, many of which are available free on this Web site. See Newsroom, Congressional Resources, and Reports and Bookstore. RAND in the 21st century continues to address difficult challenges throughout the world. In many ways, RAND's future reflects its past: anticipating emerging issues; establishing new angles of inquiry; and mapping the territory for responses by government, business, and society. Commitment to these high standards will continue to define RAND's work in the years to come.

Transactions
Details Hidden

DiaVacs, Inc. raised money in a private placement transaction

Investments
Details Hidden

Sensulin LLC engages in a biotechnology company. It develops once-a-day glucose responsive insulin that may mimic a healthy human pancreas. The company was founded by Mike Moradi, Ananth Annapragada, Daniel M. Bradbury, and Chris A. Rhodes and is headquartered in Oklahoma City, OK.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Daniel Mark Bradbury. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Daniel Mark Bradbury's profile does not indicate a business or promotional relationship of any kind between RelSci and Daniel Mark Bradbury.